Business Information
The group's principal activity are to design, manufacture and market reconstructive joint devices and bio-orthopaedic materials. The reconstructive joint devices are used to replace knee, hip and other joints that have deteriorated through disease or injury. The bio-orthopaedic materials are used to replace damaged or diseased bone and to stimulate natural bone growth. The group focuses on the higher-growth sector of advanced knee implants, bone-conserving hip implants, revision replacement implants and extremity implants, as well as on the integration of bio-orthopaedic products into reconstructive joint procedures.the group operates in the United States, Europe, Canada, Japan and other foreign countries. In Mar 2003, the group acquired certain assets from gliatech inc.
|
|
Name |
Title
|
Email
|
| Barry Bays | Executive Chmn. | N/A | | Paul Kosters | Pres. - Europe, Middle East, Africa | N/A | | Cary Hagan | VP - Marketing, Ortho Recon | N/A | | Eric Stookey | VP - North American Sales | N/A | | Frank Bono | Sr. VP - Research & Development | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 338,938 | 14,411 | | 2005 | 319,137 | 21,065 | | 2004 | 297,539 | 24,022
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
